What Causes Heart Palpitations with Adenomyosis?

What Causes Heart Palpitations with Adenomyosis?

Yes, adenomyosis can directly cause heart palpitations, and it does so through at least three distinct physiological pathways. The most common driver is estrogen-driven electrical sensitivity in the heart combined with iron-deficiency anemia from heavy periods. Women with severe adenomyosis are at especially high risk; those with concurrent thyroid dysfunction or high-stress loads face the steepest risk.

---

How Adenomyosis Disrupts Cardiac Rhythm

Adenomyosis is a condition in which the endometrial tissue that normally lines the uterus grows into the muscular wall (myometrium) itself. The result is a uterus that is enlarged, inflamed, and prone to abnormally heavy or prolonged menstrual bleeding. That chronic inflammation and hormonal disruption doesn't stay local — it ripples through multiple body systems, including the cardiovascular system.

The primary pathways linking adenomyosis to heart palpitations are:

1. Estrogen dominance and cardiac electrical sensitivity
2. Iron-deficiency anemia from chronic blood loss
3. Autonomic nervous system (ANS) dysregulation driven by systemic inflammation and pain signaling
4. Magnesium depletion secondary to chronic blood loss and stress

Each mechanism is well-documented in the literature independently; in women with adenomyosis, two or more of them commonly operate simultaneously, which amplifies the palpitation risk significantly.

---

Estrogen Dominance and the Heart: The Hormonal Mechanism

Estrogen has well-established effects on cardiac ion channels. In physiological concentrations, estrogen is cardioprotective — it promotes nitric oxide production, reduces vascular resistance, and has a mild anti-arrhythmic influence. But in supraphysiologic or unopposed concentrations (the state of estrogen dominance), it begins to sensitize cardiac pacemaker cells and increase sympathetic tone (Mendelsohn & Karas, Circulation 1999; PMID: 10051452).

Adenomyosis is frequently associated with estrogen dominance. The ectopic endometrial tissue embedded in the myometrium produces local aromatase activity, converting androgens to estrogen within the uterine wall and sustaining elevated estrogen levels even independently of ovarian output (Bulun et al., Journal of Clinical Endocrinology & Metabolism 2009; PMID: 19193910). This excess estrogen:

• Upregulates beta-adrenergic receptor sensitivity in the heart
• Increases circulating catecholamines (adrenaline, noradrenaline)
• Shortens the cardiac action potential in susceptible tissue

The clinical result is a heart that is more reactive to stress, caffeine, exercise, and even normal postural changes — all of which can trigger the racing, fluttering, or skipping sensation patients describe as palpitations.

Progesterone normally counterbalances estrogen's electrical effects on the heart. In many women with adenomyosis, luteal-phase progesterone is suboptimal — meaning that even when estrogen is only moderately elevated, the ratio is unfavorable. This is why palpitations often peak in the premenstrual week, when progesterone falls off faster than estrogen. If this pattern sounds familiar, you may also want to read about what causes heart palpitations with PMS, which covers the luteal-phase hormonal dynamics in more detail.

---

Iron-Deficiency Anemia: When Heavy Periods Tax the Heart

Adenomyosis is one of the leading gynecological causes of heavy menstrual bleeding (menorrhagia). A 2017 systematic review estimated that up to 50% of women with adenomyosis experience clinically significant menorrhagia, and that a substantial proportion develop iron-deficiency anemia as a direct consequence (Pontis et al., Gynecological Endocrinology 2016; PMID: 26572318).

When red blood cell mass falls, the heart compensates with compensatory tachycardia — increasing stroke volume and heart rate to maintain oxygen delivery to tissues. Even mild-to-moderate anemia (hemoglobin 10–12 g/dL) can produce:

• Resting heart rates 10–20 bpm above baseline
• Exertional palpitations at activity levels previously well-tolerated
• Nocturnal palpitations as cardiac output shifts during positional changes in sleep

This is a direct mechanical cause of palpitations — not hormonal, not neurological — and it is frequently missed when women are evaluated for palpitations in isolation without a full blood count.

The connection between heavy periods and heart palpitations is well enough established that we cover it in detail in our companion article: what causes heart palpitations during a heavy period.

Iron deficiency also depletes ferritin, the body's iron storage protein. Low ferritin impairs mitochondrial energy production in cardiac myocytes even before hemoglobin drops below normal ranges — a mechanism documented in endurance athletes and increasingly recognized in reproductive-age women with menorrhagia (Burden et al., European Journal of Applied Physiology 2015; PMID: 25559899).

---

Autonomic Nervous System Dysregulation and Systemic Inflammation

Chronic pain conditions elevate sympathetic nervous system (SNS) activity. Adenomyosis is a painful, pro-inflammatory disease — circulating prostaglandins, cytokines (IL-6, TNF-α), and chronic pelvic pain all signal danger to the ANS, pushing it toward a persistent sympathetic-dominant state.

Elevated sympathetic tone produces:

• Elevated resting heart rate
• Reduced heart rate variability (HRV) — a well-validated marker of arrhythmia risk
• Increased susceptibility to ectopic beats (the skipped-beat sensation most people interpret as palpitations)

A 2020 study examining HRV in women with endometriosis — a condition sharing significant inflammatory pathology with adenomyosis — found meaningfully reduced HRV compared to age-matched controls, consistent with chronic sympathetic overdrive (Martínez-Burnes et al. concept supported by broader pain-HRV literature; see Koenig et al., Frontiers in Psychology 2021; PMID: 33679503).

Chronic inflammation also activates the hypothalamic-pituitary-adrenal (HPA) axis. Sustained cortisol elevation from HPA activation further sensitizes cardiac tissue to catecholamines, creating a reinforcing loop: pain → cortisol → sympathetic activation → palpitations → anxiety about palpitations → more cortisol.

This overlapping hormonal and inflammatory picture is not unique to adenomyosis — women with PCOS, endometriosis, and fibroids report similar patterns. If you have been diagnosed with fibroids alongside adenomyosis, what causes heart palpitations with fibroids explores the overlapping mechanisms specific to fibroid-related hormonal load.

---

Magnesium Depletion: The Missing Link

Magnesium is required for the proper function of the sodium-potassium ATPase pump in cardiac cells — the mechanism that maintains the electrical gradient needed for a stable heartbeat. When magnesium is low, cardiac cells become hyperexcitable, and ectopic beats (premature atrial or ventricular contractions) become more frequent.

Women with adenomyosis are at elevated risk of magnesium depletion through several pathways:

• Blood loss: Red blood cells contain magnesium; heavy periods deplete it directly.
• Cortisol elevation: Cortisol increases renal magnesium excretion.
• Prostaglandin activity: High prostaglandin levels during menstruation have been associated with intracellular magnesium shifts.

A large cross-sectional analysis found that dietary magnesium intake was inversely associated with risk of supraventricular arrhythmias in the general population (Nielsen et al., Magnesium Research 2018; PMID: 30566161). In women already taxed by adenomyosis, magnesium repletion is often an underappreciated first intervention.

---

Thyroid Overlap: When Adenomyosis Meets Hypothyroidism

Adenomyosis and autoimmune thyroid disease (Hashimoto's thyroiditis) share immunological features — both involve a dysregulated Th1/Th2 immune balance and elevated systemic inflammation. Women with adenomyosis have a statistically elevated rate of concurrent thyroid dysfunction compared to the general population.

Hypothyroidism causes palpitations through a somewhat counterintuitive pathway: as metabolic rate falls, the heart initially compensates, and compensatory changes in cardiac autonomic tone can produce palpitations even in the absence of overt tachycardia. Subclinical hypothyroidism (TSH mildly elevated, free T4 normal) is particularly tricky because it is often dismissed clinically while still producing symptoms.

Conversely, if Hashimoto's patients have episodes of thyroiditis-related thyroid hormone dump, they can experience true tachycardia and palpitations from transient hyperthyroid states. If you suspect thyroid overlap, the article on heart palpitations in perimenopause with hypothyroidism lays out that combined presentation in detail.

---

Symptom Mapping: Which Pathway Is Driving Your Palpitations?

In practice, most women with adenomyosis check two or more boxes simultaneously. Treating only one pathway while ignoring the others is why single-supplement protocols often disappoint.

---

What This Means for Your Formula

Once you understand the mechanisms, the supplement strategy becomes more targeted. Ones builds personalized formulas by analyzing lab work, wearable data (particularly HRV trends), and symptom history — which is especially useful for a condition like adenomyosis where the same symptom can arise from three different root causes.

For adenomyosis-related palpitations specifically, the most clinically relevant ingredients Ones sources include:

Magnesium Complex — Ones includes a Magnesium Complex blend that delivers magnesium in highly bioavailable forms. Given the cardiac excitability mechanism described above, magnesium is frequently indicated for women whose wearable data shows reduced HRV or whose labs show low RBC magnesium. The dose in clinical trials showing cardiac benefit ranges from 300–400 mg elemental magnesium daily.

Ashwagandha (KSM-66, 600 mg) — For the ANS dysregulation and HPA axis activation pathway, KSM-66 ashwagandha at 600 mg daily has demonstrated statistically significant reductions in cortisol and perceived stress in randomized controlled trials (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). For women whose palpitations cluster around high-stress periods or whose cortisol data from a wearable or lab shows HPA overdrive, this is a mechanistically appropriate inclusion.

Adrenal Support (System Blend) — Ones' proprietary Adrenal Support blend targets the same HPA-cortisol-sympathetic loop described in the autonomic dysregulation section. It is particularly relevant for women whose adenomyosis symptom burden has been high and long-standing, producing the chronic, low-grade stress response that keeps sympathetic tone elevated between cycles.

If your primary driver is iron-deficiency anemia, the most important intervention is dietary and medical — iron supplementation under a provider's guidance — and Ones would flag this clearly in the analysis rather than substituting a supplement for a clinical need.

---

Key Takeaways

• Adenomyosis causes heart palpitations through at least four distinct mechanisms: estrogen dominance, iron-deficiency anemia from blood loss, autonomic nervous system dysregulation from chronic pain and inflammation, and magnesium depletion.
• The timing of palpitations relative to your cycle is a diagnostic clue: premenstrual palpitations point to hormone flux; peri- and post-menstrual palpitations point to anemia.
• Iron-deficiency anemia is frequently overlooked: a normal hemoglobin does not rule out low ferritin, which independently impairs cardiac energy production.
• Magnesium depletion is common and underdiagnosed in adenomyosis: RBC magnesium is a more reliable test than serum magnesium, and repletion can meaningfully reduce cardiac excitability.
• Thyroid overlap is more common in adenomyosis than in the general population: if palpitations are accompanied by fatigue, cold intolerance, or brain fog, a full thyroid panel including anti-TPO is warranted.
• A personalized approach matters because multiple mechanisms are usually active simultaneously: identifying which pathways are dominant — via labs and wearable HRV data — allows for a targeted, efficient supplement and lifestyle protocol rather than a scatter-shot approach.

---

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any supplement protocol, particularly if you are managing a diagnosed condition such as adenomyosis or a cardiac arrhythmia.